GlassScriptPhysician profile
Matthew S Baron
NPI 1255513644
$4,578.01
in general payments reported to CMS, 2019-2025
37 companies · $1,459 in 2025
The $1,459 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,190 · 2020: $243 · 2022: $14.59 · 2023: $585 · 2024: $1,087 · 2025: $1,459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,130.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $686.67 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $572.27 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $524.28 | 2019-2025 | |
| Lilly USA, LLC | $498.27 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Abbvie INC. | $314.87 | 2023-2025 | Vraylar |
| Amgen INC. | $261.84 | 2019-2025 | Otezla, Repatha, Krystexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $246.16 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Astellas Pharma US INC | $141.65 | 2020-2025 | Veozah |
| Depuy Synthes Sales INC. | $125.76 | 2019 | |
| Exact Sciences Corporation | $119.14 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Mylan Specialty L.P. | $110.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $103.74 | 2025 | |
| Glaxosmithkline, LLC. | $89.89 | 2023-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Axsome Therapeutics, INC. | $84.64 | 2023-2025 | Auvelity, Sunosi |
| E.R. Squibb & Sons, L.L.C. | $64.56 | 2019-2025 | Eliquis, Camzyos |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Baron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.